Cite
MLA Citation
Shanshan Hu et al.. “Cost‐utility analysis of semaglutide for type 2 diabetes after its addition to the National Medical Insurance System in China.” Diabetes, obesity & metabolism, vol. 25, no. 2, 2023, pp. 387–397. http://access.bl.uk/ark:/81055/vdc_100174258417.0x000017